Could a malaria drug help kids with rare lung disease?
NCT ID NCT03822780
First seen Mar 21, 2026 · Last updated May 06, 2026 · Updated 9 times
Summary
This study looked at whether hydroxychloroquine can help children with a rare genetic lung condition that affects surfactant, a substance that keeps lungs open. 25 children took the drug, and doctors checked if their oxygen needs improved over 6 months. The goal was to see if the drug could control the disease and reduce breathing problems.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SURFACTANT DYSFUNCTION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Children's hospital of Fudan University
Shanghai, Shanghai Municipality, 201102, China
Conditions
Explore the condition pages connected to this study.